Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,769
archived clinical trials in
Migraine Headaches

An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine
An Open-label, LonG-term, Safety Study of LAsmiDItan (100 mg and 200 mg) in the Acute Treatment Of MigRaine (GLADIATOR)
Status: Enrolling
Updated:  12/31/1969
Radiant Research, Inc.
mi
from
Anderson, SC
An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine
An Open-label, LonG-term, Safety Study of LAsmiDItan (100 mg and 200 mg) in the Acute Treatment Of MigRaine (GLADIATOR)
Status: Enrolling
Updated: 12/31/1969
Radiant Research, Inc.
mi
from
Anderson, SC
Click here to add this to my saved trials
An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine
An Open-label, LonG-term, Safety Study of LAsmiDItan (100 mg and 200 mg) in the Acute Treatment Of MigRaine (GLADIATOR)
Status: Enrolling
Updated:  12/31/1969
Radiant Research
mi
from
Greer, SC
An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine
An Open-label, LonG-term, Safety Study of LAsmiDItan (100 mg and 200 mg) in the Acute Treatment Of MigRaine (GLADIATOR)
Status: Enrolling
Updated: 12/31/1969
Radiant Research
mi
from
Greer, SC
Click here to add this to my saved trials
An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine
An Open-label, LonG-term, Safety Study of LAsmiDItan (100 mg and 200 mg) in the Acute Treatment Of MigRaine (GLADIATOR)
Status: Enrolling
Updated:  12/31/1969
Holston Medical Group Clinical Research
mi
from
Kingsport, TN
An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine
An Open-label, LonG-term, Safety Study of LAsmiDItan (100 mg and 200 mg) in the Acute Treatment Of MigRaine (GLADIATOR)
Status: Enrolling
Updated: 12/31/1969
Holston Medical Group Clinical Research
mi
from
Kingsport, TN
Click here to add this to my saved trials
An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine
An Open-label, LonG-term, Safety Study of LAsmiDItan (100 mg and 200 mg) in the Acute Treatment Of MigRaine (GLADIATOR)
Status: Enrolling
Updated:  12/31/1969
New Orleans Center for Clinical Research
mi
from
Knoxville, TN
An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine
An Open-label, LonG-term, Safety Study of LAsmiDItan (100 mg and 200 mg) in the Acute Treatment Of MigRaine (GLADIATOR)
Status: Enrolling
Updated: 12/31/1969
New Orleans Center for Clinical Research
mi
from
Knoxville, TN
Click here to add this to my saved trials
An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine
An Open-label, LonG-term, Safety Study of LAsmiDItan (100 mg and 200 mg) in the Acute Treatment Of MigRaine (GLADIATOR)
Status: Enrolling
Updated:  12/31/1969
Clinical NeuroScience Solutions, Inc.
mi
from
Memphis, TN
An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine
An Open-label, LonG-term, Safety Study of LAsmiDItan (100 mg and 200 mg) in the Acute Treatment Of MigRaine (GLADIATOR)
Status: Enrolling
Updated: 12/31/1969
Clinical NeuroScience Solutions, Inc.
mi
from
Memphis, TN
Click here to add this to my saved trials
An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine
An Open-label, LonG-term, Safety Study of LAsmiDItan (100 mg and 200 mg) in the Acute Treatment Of MigRaine (GLADIATOR)
Status: Enrolling
Updated:  12/31/1969
FutureSearch Trials
mi
from
Austin, TX
An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine
An Open-label, LonG-term, Safety Study of LAsmiDItan (100 mg and 200 mg) in the Acute Treatment Of MigRaine (GLADIATOR)
Status: Enrolling
Updated: 12/31/1969
FutureSearch Trials
mi
from
Austin, TX
Click here to add this to my saved trials
An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine
An Open-label, LonG-term, Safety Study of LAsmiDItan (100 mg and 200 mg) in the Acute Treatment Of MigRaine (GLADIATOR)
Status: Enrolling
Updated:  12/31/1969
ACRC Trials
mi
from
Austin, TX
An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine
An Open-label, LonG-term, Safety Study of LAsmiDItan (100 mg and 200 mg) in the Acute Treatment Of MigRaine (GLADIATOR)
Status: Enrolling
Updated: 12/31/1969
ACRC Trials
mi
from
Austin, TX
Click here to add this to my saved trials
An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine
An Open-label, LonG-term, Safety Study of LAsmiDItan (100 mg and 200 mg) in the Acute Treatment Of MigRaine (GLADIATOR)
Status: Enrolling
Updated:  12/31/1969
ACRC Trials
mi
from
Carrollton, TX
An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine
An Open-label, LonG-term, Safety Study of LAsmiDItan (100 mg and 200 mg) in the Acute Treatment Of MigRaine (GLADIATOR)
Status: Enrolling
Updated: 12/31/1969
ACRC Trials
mi
from
Carrollton, TX
Click here to add this to my saved trials
An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine
An Open-label, LonG-term, Safety Study of LAsmiDItan (100 mg and 200 mg) in the Acute Treatment Of MigRaine (GLADIATOR)
Status: Enrolling
Updated:  12/31/1969
FutureSearch Trials
mi
from
Dallas, TX
An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine
An Open-label, LonG-term, Safety Study of LAsmiDItan (100 mg and 200 mg) in the Acute Treatment Of MigRaine (GLADIATOR)
Status: Enrolling
Updated: 12/31/1969
FutureSearch Trials
mi
from
Dallas, TX
Click here to add this to my saved trials
An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine
An Open-label, LonG-term, Safety Study of LAsmiDItan (100 mg and 200 mg) in the Acute Treatment Of MigRaine (GLADIATOR)
Status: Enrolling
Updated:  12/31/1969
Radiant Research - Dallas North
mi
from
Dallas, TX
An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine
An Open-label, LonG-term, Safety Study of LAsmiDItan (100 mg and 200 mg) in the Acute Treatment Of MigRaine (GLADIATOR)
Status: Enrolling
Updated: 12/31/1969
Radiant Research - Dallas North
mi
from
Dallas, TX
Click here to add this to my saved trials
An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine
An Open-label, LonG-term, Safety Study of LAsmiDItan (100 mg and 200 mg) in the Acute Treatment Of MigRaine (GLADIATOR)
Status: Enrolling
Updated:  12/31/1969
ACRC Trials
mi
from
Plano, TX
An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine
An Open-label, LonG-term, Safety Study of LAsmiDItan (100 mg and 200 mg) in the Acute Treatment Of MigRaine (GLADIATOR)
Status: Enrolling
Updated: 12/31/1969
ACRC Trials
mi
from
Plano, TX
Click here to add this to my saved trials
An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine
An Open-label, LonG-term, Safety Study of LAsmiDItan (100 mg and 200 mg) in the Acute Treatment Of MigRaine (GLADIATOR)
Status: Enrolling
Updated:  12/31/1969
Plano Internal Medicine Associates
mi
from
Plano, TX
An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine
An Open-label, LonG-term, Safety Study of LAsmiDItan (100 mg and 200 mg) in the Acute Treatment Of MigRaine (GLADIATOR)
Status: Enrolling
Updated: 12/31/1969
Plano Internal Medicine Associates
mi
from
Plano, TX
Click here to add this to my saved trials
An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine
An Open-label, LonG-term, Safety Study of LAsmiDItan (100 mg and 200 mg) in the Acute Treatment Of MigRaine (GLADIATOR)
Status: Enrolling
Updated:  12/31/1969
Radiant Research - San Antonio
mi
from
San Antonio, TX
An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine
An Open-label, LonG-term, Safety Study of LAsmiDItan (100 mg and 200 mg) in the Acute Treatment Of MigRaine (GLADIATOR)
Status: Enrolling
Updated: 12/31/1969
Radiant Research - San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine
An Open-label, LonG-term, Safety Study of LAsmiDItan (100 mg and 200 mg) in the Acute Treatment Of MigRaine (GLADIATOR)
Status: Enrolling
Updated:  12/31/1969
MacGregor Medical Center
mi
from
San Antonio, TX
An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine
An Open-label, LonG-term, Safety Study of LAsmiDItan (100 mg and 200 mg) in the Acute Treatment Of MigRaine (GLADIATOR)
Status: Enrolling
Updated: 12/31/1969
MacGregor Medical Center
mi
from
San Antonio, TX
Click here to add this to my saved trials
An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine
An Open-label, LonG-term, Safety Study of LAsmiDItan (100 mg and 200 mg) in the Acute Treatment Of MigRaine (GLADIATOR)
Status: Enrolling
Updated:  12/31/1969
Ericksen Research And Development
mi
from
Clinton, UT
An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine
An Open-label, LonG-term, Safety Study of LAsmiDItan (100 mg and 200 mg) in the Acute Treatment Of MigRaine (GLADIATOR)
Status: Enrolling
Updated: 12/31/1969
Ericksen Research And Development
mi
from
Clinton, UT
Click here to add this to my saved trials
An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine
An Open-label, LonG-term, Safety Study of LAsmiDItan (100 mg and 200 mg) in the Acute Treatment Of MigRaine (GLADIATOR)
Status: Enrolling
Updated:  12/31/1969
J. Lewis Research, Inc.
mi
from
Salt Lake City, UT
An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine
An Open-label, LonG-term, Safety Study of LAsmiDItan (100 mg and 200 mg) in the Acute Treatment Of MigRaine (GLADIATOR)
Status: Enrolling
Updated: 12/31/1969
J. Lewis Research, Inc.
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine
An Open-label, LonG-term, Safety Study of LAsmiDItan (100 mg and 200 mg) in the Acute Treatment Of MigRaine (GLADIATOR)
Status: Enrolling
Updated:  12/31/1969
Jordan River Family Medicine
mi
from
South Jordan, UT
An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine
An Open-label, LonG-term, Safety Study of LAsmiDItan (100 mg and 200 mg) in the Acute Treatment Of MigRaine (GLADIATOR)
Status: Enrolling
Updated: 12/31/1969
Jordan River Family Medicine
mi
from
South Jordan, UT
Click here to add this to my saved trials
An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine
An Open-label, LonG-term, Safety Study of LAsmiDItan (100 mg and 200 mg) in the Acute Treatment Of MigRaine (GLADIATOR)
Status: Enrolling
Updated:  12/31/1969
MultiCare Tacoma General Hospital
mi
from
Tacoma, WA
An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine
An Open-label, LonG-term, Safety Study of LAsmiDItan (100 mg and 200 mg) in the Acute Treatment Of MigRaine (GLADIATOR)
Status: Enrolling
Updated: 12/31/1969
MultiCare Tacoma General Hospital
mi
from
Tacoma, WA
Click here to add this to my saved trials
An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine
An Open-label, LonG-term, Safety Study of LAsmiDItan (100 mg and 200 mg) in the Acute Treatment Of MigRaine (GLADIATOR)
Status: Enrolling
Updated:  12/31/1969
Warner Family Practice
mi
from
Chandler, AZ
An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine
An Open-label, LonG-term, Safety Study of LAsmiDItan (100 mg and 200 mg) in the Acute Treatment Of MigRaine (GLADIATOR)
Status: Enrolling
Updated: 12/31/1969
Warner Family Practice
mi
from
Chandler, AZ
Click here to add this to my saved trials
An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine
An Open-label, LonG-term, Safety Study of LAsmiDItan (100 mg and 200 mg) in the Acute Treatment Of MigRaine (GLADIATOR)
Status: Enrolling
Updated:  12/31/1969
Neurological Physicians of Arizona
mi
from
Gilbert, AZ
An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine
An Open-label, LonG-term, Safety Study of LAsmiDItan (100 mg and 200 mg) in the Acute Treatment Of MigRaine (GLADIATOR)
Status: Enrolling
Updated: 12/31/1969
Neurological Physicians of Arizona
mi
from
Gilbert, AZ
Click here to add this to my saved trials
An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine
An Open-label, LonG-term, Safety Study of LAsmiDItan (100 mg and 200 mg) in the Acute Treatment Of MigRaine (GLADIATOR)
Status: Enrolling
Updated:  12/31/1969
Central Arizona Medical Associates, PC
mi
from
Mesa, AZ
An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine
An Open-label, LonG-term, Safety Study of LAsmiDItan (100 mg and 200 mg) in the Acute Treatment Of MigRaine (GLADIATOR)
Status: Enrolling
Updated: 12/31/1969
Central Arizona Medical Associates, PC
mi
from
Mesa, AZ
Click here to add this to my saved trials
An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine
An Open-label, LonG-term, Safety Study of LAsmiDItan (100 mg and 200 mg) in the Acute Treatment Of MigRaine (GLADIATOR)
Status: Enrolling
Updated:  12/31/1969
Family Practice Specialists, Ltd
mi
from
Phoenix, AZ
An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine
An Open-label, LonG-term, Safety Study of LAsmiDItan (100 mg and 200 mg) in the Acute Treatment Of MigRaine (GLADIATOR)
Status: Enrolling
Updated: 12/31/1969
Family Practice Specialists, Ltd
mi
from
Phoenix, AZ
Click here to add this to my saved trials
An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine
An Open-label, LonG-term, Safety Study of LAsmiDItan (100 mg and 200 mg) in the Acute Treatment Of MigRaine (GLADIATOR)
Status: Enrolling
Updated:  12/31/1969
Radiant Research
mi
from
Scottsdale, AZ
An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine
An Open-label, LonG-term, Safety Study of LAsmiDItan (100 mg and 200 mg) in the Acute Treatment Of MigRaine (GLADIATOR)
Status: Enrolling
Updated: 12/31/1969
Radiant Research
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine
An Open-label, LonG-term, Safety Study of LAsmiDItan (100 mg and 200 mg) in the Acute Treatment Of MigRaine (GLADIATOR)
Status: Enrolling
Updated:  12/31/1969
Anderson Clinical Research
mi
from
Redlands, CA
An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine
An Open-label, LonG-term, Safety Study of LAsmiDItan (100 mg and 200 mg) in the Acute Treatment Of MigRaine (GLADIATOR)
Status: Enrolling
Updated: 12/31/1969
Anderson Clinical Research
mi
from
Redlands, CA
Click here to add this to my saved trials
An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine
An Open-label, LonG-term, Safety Study of LAsmiDItan (100 mg and 200 mg) in the Acute Treatment Of MigRaine (GLADIATOR)
Status: Enrolling
Updated:  12/31/1969
Radiant Research - Vista CA
mi
from
Vista, CA
An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine
An Open-label, LonG-term, Safety Study of LAsmiDItan (100 mg and 200 mg) in the Acute Treatment Of MigRaine (GLADIATOR)
Status: Enrolling
Updated: 12/31/1969
Radiant Research - Vista CA
mi
from
Vista, CA
Click here to add this to my saved trials
An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine
An Open-label, LonG-term, Safety Study of LAsmiDItan (100 mg and 200 mg) in the Acute Treatment Of MigRaine (GLADIATOR)
Status: Enrolling
Updated:  12/31/1969
Nova Clinical Research, Llc
mi
from
Bradenton, FL
An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine
An Open-label, LonG-term, Safety Study of LAsmiDItan (100 mg and 200 mg) in the Acute Treatment Of MigRaine (GLADIATOR)
Status: Enrolling
Updated: 12/31/1969
Nova Clinical Research, Llc
mi
from
Bradenton, FL
Click here to add this to my saved trials
An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine
An Open-label, LonG-term, Safety Study of LAsmiDItan (100 mg and 200 mg) in the Acute Treatment Of MigRaine (GLADIATOR)
Status: Enrolling
Updated:  12/31/1969
Synexus Clinical Research GmbH
mi
from
Frankfurt am Main,
An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine
An Open-label, LonG-term, Safety Study of LAsmiDItan (100 mg and 200 mg) in the Acute Treatment Of MigRaine (GLADIATOR)
Status: Enrolling
Updated: 12/31/1969
Synexus Clinical Research GmbH
mi
from
Frankfurt am Main,
Click here to add this to my saved trials
DFN-11 Injection in Episodic Migraine With or Without Aura
Status: Enrolling
Updated:  12/31/1969
Dr. Reddy's Investigational Site #18
mi
from
Santa Monica, CA
DFN-11 Injection in Episodic Migraine With or Without Aura
Status: Enrolling
Updated: 12/31/1969
Dr. Reddy's Investigational Site #18
mi
from
Santa Monica, CA
Click here to add this to my saved trials
DFN-11 Injection in Episodic Migraine With or Without Aura
Status: Enrolling
Updated:  12/31/1969
Dr. Reddy's Investigational Site #24
mi
from
Jacksonville, FL
DFN-11 Injection in Episodic Migraine With or Without Aura
Status: Enrolling
Updated: 12/31/1969
Dr. Reddy's Investigational Site #24
mi
from
Jacksonville, FL
Click here to add this to my saved trials
DFN-11 Injection in Episodic Migraine With or Without Aura
Status: Enrolling
Updated:  12/31/1969
Dr. Reddy's Investigational Site #23
mi
from
Maitland, FL
DFN-11 Injection in Episodic Migraine With or Without Aura
Status: Enrolling
Updated: 12/31/1969
Dr. Reddy's Investigational Site #23
mi
from
Maitland, FL
Click here to add this to my saved trials
DFN-11 Injection in Episodic Migraine With or Without Aura
Status: Enrolling
Updated:  12/31/1969
Dr. Reddy's Investigational Site #27
mi
from
Boise, ID
DFN-11 Injection in Episodic Migraine With or Without Aura
Status: Enrolling
Updated: 12/31/1969
Dr. Reddy's Investigational Site #27
mi
from
Boise, ID
Click here to add this to my saved trials
DFN-11 Injection in Episodic Migraine With or Without Aura
Status: Enrolling
Updated:  12/31/1969
Dr. Reddy's Investigational Site #20
mi
from
Watertown, MA
DFN-11 Injection in Episodic Migraine With or Without Aura
Status: Enrolling
Updated: 12/31/1969
Dr. Reddy's Investigational Site #20
mi
from
Watertown, MA
Click here to add this to my saved trials
DFN-11 Injection in Episodic Migraine With or Without Aura
Status: Enrolling
Updated:  12/31/1969
Dr. Reddy's Investigational Site #19
mi
from
Ann Arbor, MI
DFN-11 Injection in Episodic Migraine With or Without Aura
Status: Enrolling
Updated: 12/31/1969
Dr. Reddy's Investigational Site #19
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
DFN-11 Injection in Episodic Migraine With or Without Aura
Status: Enrolling
Updated:  12/31/1969
Dr. Reddy's Investigational Site #13
mi
from
Springfield, MO
DFN-11 Injection in Episodic Migraine With or Without Aura
Status: Enrolling
Updated: 12/31/1969
Dr. Reddy's Investigational Site #13
mi
from
Springfield, MO
Click here to add this to my saved trials
DFN-11 Injection in Episodic Migraine With or Without Aura
Status: Enrolling
Updated:  12/31/1969
Dr. Reddy's Investigational Site #12
mi
from
Albuquerque, NM
DFN-11 Injection in Episodic Migraine With or Without Aura
Status: Enrolling
Updated: 12/31/1969
Dr. Reddy's Investigational Site #12
mi
from
Albuquerque, NM
Click here to add this to my saved trials
DFN-11 Injection in Episodic Migraine With or Without Aura
Status: Enrolling
Updated:  12/31/1969
Dr. Reddy's Investigational Site #10
mi
from
Williamsville, NY
DFN-11 Injection in Episodic Migraine With or Without Aura
Status: Enrolling
Updated: 12/31/1969
Dr. Reddy's Investigational Site #10
mi
from
Williamsville, NY
Click here to add this to my saved trials
DFN-11 Injection in Episodic Migraine With or Without Aura
Status: Enrolling
Updated:  12/31/1969
Dr. Reddy's Investigational Site #26
mi
from
Greensboro, NC
DFN-11 Injection in Episodic Migraine With or Without Aura
Status: Enrolling
Updated: 12/31/1969
Dr. Reddy's Investigational Site #26
mi
from
Greensboro, NC
Click here to add this to my saved trials
DFN-11 Injection in Episodic Migraine With or Without Aura
Status: Enrolling
Updated:  12/31/1969
Dr. Reddy's Investigational Site #15
mi
from
Cleveland, OH
DFN-11 Injection in Episodic Migraine With or Without Aura
Status: Enrolling
Updated: 12/31/1969
Dr. Reddy's Investigational Site #15
mi
from
Cleveland, OH
Click here to add this to my saved trials
DFN-11 Injection in Episodic Migraine With or Without Aura
Status: Enrolling
Updated:  12/31/1969
Dr. Reddy's Investigational Site #25
mi
from
Memphis, TN
DFN-11 Injection in Episodic Migraine With or Without Aura
Status: Enrolling
Updated: 12/31/1969
Dr. Reddy's Investigational Site #25
mi
from
Memphis, TN
Click here to add this to my saved trials
DFN-11 Injection in Episodic Migraine With or Without Aura
Status: Enrolling
Updated:  12/31/1969
Dr. Reddy's Investigational Site #14
mi
from
Dallas, TX
DFN-11 Injection in Episodic Migraine With or Without Aura
Status: Enrolling
Updated: 12/31/1969
Dr. Reddy's Investigational Site #14
mi
from
Dallas, TX
Click here to add this to my saved trials
DFN-11 Injection in Episodic Migraine With or Without Aura
Status: Enrolling
Updated:  12/31/1969
Dr. Reddy's Investigational Site #16
mi
from
Hurst, TX
DFN-11 Injection in Episodic Migraine With or Without Aura
Status: Enrolling
Updated: 12/31/1969
Dr. Reddy's Investigational Site #16
mi
from
Hurst, TX
Click here to add this to my saved trials
DFN-11 Injection in Episodic Migraine With or Without Aura
Status: Enrolling
Updated:  12/31/1969
Dr. Reddy's Investigational Site #17
mi
from
West Jordan, UT
DFN-11 Injection in Episodic Migraine With or Without Aura
Status: Enrolling
Updated: 12/31/1969
Dr. Reddy's Investigational Site #17
mi
from
West Jordan, UT
Click here to add this to my saved trials
DFN-11 Injection in Episodic Migraine With or Without Aura
Status: Enrolling
Updated:  12/31/1969
Dr. Reddy's Investigational Site #21
mi
from
Mount Pleasant, SC
DFN-11 Injection in Episodic Migraine With or Without Aura
Status: Enrolling
Updated: 12/31/1969
Dr. Reddy's Investigational Site #21
mi
from
Mount Pleasant, SC
Click here to add this to my saved trials
Pilot Study of Two Different Strengths of DFN-11 Injection for Rapidly Escalating Migraine
Randomized, Double-Blind, Crossover, Comparator Pilot Study of DFN-11 Injection (Strength A vs. Strength B) for Rapidly Escalating Migraine
Status: Enrolling
Updated:  12/31/1969
Clinvest
mi
from
Springfield, MO
Pilot Study of Two Different Strengths of DFN-11 Injection for Rapidly Escalating Migraine
Randomized, Double-Blind, Crossover, Comparator Pilot Study of DFN-11 Injection (Strength A vs. Strength B) for Rapidly Escalating Migraine
Status: Enrolling
Updated: 12/31/1969
Clinvest
mi
from
Springfield, MO
Click here to add this to my saved trials
Acute Treatment of Migraine With e-TNS
Multi-center, Double-blind, Randomized, Sham-controlled Trial on the Acute Treatment of Migraine With the Cefaly® Device
Status: Enrolling
Updated:  12/31/1969
Rowe Neurology Institute
mi
from
Lenexa, KA
Acute Treatment of Migraine With e-TNS
Multi-center, Double-blind, Randomized, Sham-controlled Trial on the Acute Treatment of Migraine With the Cefaly® Device
Status: Enrolling
Updated: 12/31/1969
Rowe Neurology Institute
mi
from
Lenexa, KA
Click here to add this to my saved trials
Acute Treatment of Migraine With e-TNS
Multi-center, Double-blind, Randomized, Sham-controlled Trial on the Acute Treatment of Migraine With the Cefaly® Device
Status: Enrolling
Updated:  12/31/1969
Yale University School of Medicine
mi
from
New Haven, CT
Acute Treatment of Migraine With e-TNS
Multi-center, Double-blind, Randomized, Sham-controlled Trial on the Acute Treatment of Migraine With the Cefaly® Device
Status: Enrolling
Updated: 12/31/1969
Yale University School of Medicine
mi
from
New Haven, CT
Click here to add this to my saved trials
Acute Treatment of Migraine With e-TNS
Multi-center, Double-blind, Randomized, Sham-controlled Trial on the Acute Treatment of Migraine With the Cefaly® Device
Status: Enrolling
Updated:  12/31/1969
Columbia University Medical Center
mi
from
New York, NY
Acute Treatment of Migraine With e-TNS
Multi-center, Double-blind, Randomized, Sham-controlled Trial on the Acute Treatment of Migraine With the Cefaly® Device
Status: Enrolling
Updated: 12/31/1969
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Birmingham, AL
A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Phoenix, AZ
A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Tucson, AZ
A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Tucson, AZ
Click here to add this to my saved trials